| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/15/2004 | WO2004033632A3 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
| 07/15/2004 | WO2004032848A3 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 07/15/2004 | WO2004032846A3 Triazolone and triazolethione derivatives |
| 07/15/2004 | WO2004031153A3 Enantioselective alkylation of tricyclic compounds |
| 07/15/2004 | WO2004006846A3 Receptor-type kinase modulators and methods of use |
| 07/15/2004 | WO2004004714A1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | WO2003011853A8 6-aryl-4-aminopicolinates and their use as herbicides |
| 07/15/2004 | US20040138492 Water-soluble dithioesters and method for polymerization thereof |
| 07/15/2004 | US20040138466 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles |
| 07/15/2004 | US20040138461 Methods for the syntheses of alfentanil sufentanil and remifentanil |
| 07/15/2004 | US20040138452 Discoloration inhibition, colorfastness for candle wax; polymers |
| 07/15/2004 | US20040138450 Agriculture salts and oxides |
| 07/15/2004 | US20040138332 Antifouling protective coatings |
| 07/15/2004 | US20040138309 Factor x inhibitor; anticoagulants |
| 07/15/2004 | US20040138286 Rho kinase inhibitors |
| 07/15/2004 | US20040138284 Indol-3-yl derivatives |
| 07/15/2004 | US20040138283 Deep vein thrombosis, noninsulin dependent diabetes, atherosclerosis, and pulmonary fibrosis treatment; cardiovascular and brain disorders |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138273 Carbocycle based inhibitors of glycogen synthase kinase 3 |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138259 Pain management |
| 07/15/2004 | US20040138257 Chemical derivatives and their application as antitelomerase agent |
| 07/15/2004 | US20040138256 Process for the preparation of imidazole compounds |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138254 Central nervous system disorders; analgesics; headaches |
| 07/15/2004 | US20040138246 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 07/15/2004 | US20040138243 Antiinflammatory agents; asthma; Alzheimer's disease; Aids; antidiabetic agents; inflmamtory bowel disorders; anticholesterol agents; antitumor agenst |
| 07/15/2004 | US20040138242 Dihydropyrimidines and uses thereof |
| 07/15/2004 | US20040138230 Psychological and central nervous system disorders; alzheimer's disease; Huntington's disease |
| 07/15/2004 | US20040138228 Novel compounds with analgesic effect |
| 07/15/2004 | US20040138227 Antiserotonine agents; antidepressants |
| 07/15/2004 | US20040138226 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 07/15/2004 | US20040138223 Novel amide derivatives and medicinal use thereof ugs |
| 07/15/2004 | US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics |
| 07/15/2004 | US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 07/15/2004 | US20040138208 Analgesics; central nervous system disorders; asthma; rhinitis; antiarthritic agents; inflammatory bowel disorders |
| 07/15/2004 | US20040138207 Antitumor agents |
| 07/15/2004 | US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 07/15/2004 | US20040138203 Antiserotonine agents |
| 07/15/2004 | US20040138201 Prevent forming deposits of amyloid protein on nervous systems; Alzheimer's disease; Down syndrome |
| 07/15/2004 | DE10300017A1 Selektive MMP 13 Inhibitoren Selective MMP inhibitors 13 |
| 07/15/2004 | CA2512099A1 New pyridazin-3(2h)-one derivatives |
| 07/15/2004 | CA2511989A1 Novel benzamide derivatives and process for producing the same |
| 07/15/2004 | CA2511601A1 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators |
| 07/15/2004 | CA2511349A1 New substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/15/2004 | CA2511235A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors |
| 07/15/2004 | CA2511199A1 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/15/2004 | CA2510298A1 Acyclic pyrazole compounds |
| 07/15/2004 | CA2509565A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds |
| 07/15/2004 | CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | CA2508956A1 Mitotic kinesin inhibitors |
| 07/15/2004 | CA2508917A1 Therapeutic agents |
| 07/15/2004 | CA2507958A1 Pyrazole compounds as integrin receptor antagonists derivatives |
| 07/15/2004 | CA2485375A1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 07/14/2004 | EP1437385A1 Novel anthrapyridone compounds,water-base magenta ink compositions,and ink-jet recording process |
| 07/14/2004 | EP1437352A1 Benzimidazole compound, process for producing the same, and use thereof |
| 07/14/2004 | EP1437351A1 Amine derivative |
| 07/14/2004 | EP1437348A1 6-methyl-2,4-diamino-pyrimidine derivatives, process for preparation, compositions containing them and their uses as basic neutralising agents |
| 07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
| 07/14/2004 | EP1436284A1 Synthesis of 4- (z)-(4-bromophenyl)(ethoxyimino)methyl]-1'- 2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 07/14/2004 | EP1436282A1 Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts |
| 07/14/2004 | EP1436281A1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436267A1 Lactam derivatives as antagonists for human 11cby receptors |
| 07/14/2004 | EP1436266A2 Methods and compositions of novel triazine compounds |
| 07/14/2004 | EP1436259A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors |
| 07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/14/2004 | EP1435958A1 Use of phosphorodiesterase iv inhibitors |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/14/2004 | EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 07/14/2004 | EP1435947A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 07/14/2004 | EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/14/2004 | EP1218449B1 Monoazo dyestuffs useful for colour filters and ink jet printing |
| 07/14/2004 | EP1204323B1 Fungicides |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1077940B1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 07/14/2004 | EP0983248B1 Analogs of duocarmycin and cc-1065 |
| 07/14/2004 | EP0871615B1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors |
| 07/14/2004 | CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer |
| 07/14/2004 | CN1512991A 吡咯烷双环化合物 Pyrrolidine bicyclic compound |
| 07/14/2004 | CN1512988A Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1511837A Intermediate for heterocyclic compound in preparing rotamase inhibitor |
| 07/14/2004 | CN1511832A Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |
| 07/14/2004 | CN1157389C Quinolinecarboxylic acid derivative or salts thereof |
| 07/14/2004 | CN1157386C Trisubstituted 1,3,5-triazine derivatives for treatment by HIV infections |
| 07/14/2004 | CN1157380C Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants agents |
| 07/13/2004 | US6762287 Storage stable concentrates; red shades; dyeing paper, leather and glass fibers |
| 07/13/2004 | US6762197 Fungicides |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |